Nature’s Sunshine Reports Strong First Quarter 2025 Results

22 hours ago

LEHI, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Nature’s Sunshine"), a leading manufacturer of…

Comscore Reports First Quarter 2025 Results

22 hours ago

RESTON, Va., May 06, 2025 (GLOBE NEWSWIRE) -- Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating…

Weyco Reports First Quarter Sales and Earnings

22 hours ago

MILWAUKEE, May 06, 2025 (GLOBE NEWSWIRE) -- Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced…

INNOVATE Corp. Announces First Quarter 2025 Results

22 hours ago

- Infrastructure: DBM Global first quarter revenue of $264.9 million -- Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) System Received FDA…

Astera Labs Announces Financial Results for the First Quarter of Fiscal Year 2025

22 hours ago

Record quarterly revenue of $159.4 million, up 13% QoQ and 144% YoY Strong demand for PCIe scale-up and Ethernet scale-out…

Devon Energy Reports First-Quarter 2025 Results and Declares Quarterly Dividend

22 hours ago

OKLAHOMA CITY, May 06, 2025 (GLOBE NEWSWIRE) -- Devon Energy Corp. (NYSE: DVN) today reported financial and operational results for…

Gulf Island Reports First Quarter 2025 Results

22 hours ago

THE WOODLANDS, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Gulf Island Fabrication, Inc. (NASDAQ: GIFI) (“Gulf Island” or the “Company”),…

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

22 hours ago

IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of…

Lantheus Announces Sale of SPECT Business to SHINE Technologies

22 hours ago

Enables Lantheus to focus on innovative radiopharmaceuticals, while maximizing the value of its SPECT business SHINE will acquire products TechneLite®,…

Voyager Reports First Quarter 2025 Financial and Operating Results

22 hours ago

– Tau silencing gene therapy VY1706 to be featured in oral presentation at ASGCT 2025; has shown up to 73%…

This website uses cookies.